dr. ellis on immunotherapy in her2 breast cancer
Published 6 years ago • 342 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
0:58
dr. ellis on anticipated er /her2- breast cancer paradigms
-
1:32
dr. verma on immunotherapy in her2 breast cancer
-
1:25
dr. ellis on neoadjuvant endocrine therapy for breast cancer
-
1:33
dr. rimawi on the clinical need for immunotherapy in her2-positive breast cancer
-
1:52
dr. ellis on resistance to endocrine therapy in hr metastatic breast cancer
-
0:51
dr. tripathy discusses immunotherapy in her2 breast cancer
-
0:22
copy of dr. ellis on abemaciclib in hr-positive breast cancer
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
1:39
dr. ellis on abemaciclib in hr-positive breast cancer
-
0:34
future role of immunotherapy in her2 breast cancer
-
1:00
dr. carey on possibility of immunotherapy in her2 breast cancer
-
1:43
dr. roussos torres on the potential for immunotherapy in her2 breast cancer
-
1:24
dr. ellis on adjuvant cdk4/6 inhibition in hr-positive breast cancer
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
1:28
dr. tripathy on immunotherapy potential in her2-positive breast cancer
-
0:52
dr. graff on future research with immunotherapy in breast cancer
-
1:55
dr. tolaney on abemaciclib plus pembrolizumab for hr , her2- breast cancer
-
1:33
dr. matthew j. ellis on neoadjuvant palbociclib in primary breast cancer
-
2:05
dr. ellis on potential impact of cdk4/6 inhibitors in breast cancer